CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 279 filers reported holding CONMED CORP in Q1 2022. The put-call ratio across all filers is 3.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,409,712 | -16.0% | 43,725 | +13.2% | 0.27% | -12.8% |
| Q2 2023 | $5,250,813 | +5.9% | 38,640 | -59.5% | 0.31% | -0.9% |
| Q1 2023 | $4,960,219 | +116721.0% | 95,422 | +99.2% | 0.32% | +6.4% |
| Q4 2022 | $4,246 | -99.9% | 47,906 | -1.2% | 0.30% | +4.6% |
| Q3 2022 | $3,886,000 | -11.5% | 48,471 | +5.7% | 0.28% | +1.8% |
| Q2 2022 | $4,391,000 | -36.5% | 45,853 | -1.5% | 0.28% | -22.7% |
| Q1 2022 | $6,916,000 | +10.0% | 46,558 | +5.0% | 0.36% | +18.8% |
| Q4 2021 | $6,285,000 | -10.7% | 44,335 | -17.6% | 0.30% | -13.6% |
| Q3 2021 | $7,041,000 | -1.5% | 53,820 | +3.5% | 0.35% | -1.7% |
| Q2 2021 | $7,148,000 | +7.7% | 52,011 | +2.3% | 0.36% | +3.2% |
| Q1 2021 | $6,639,000 | +16.5% | 50,840 | -0.1% | 0.35% | +22.6% |
| Q4 2020 | $5,701,000 | -17.1% | 50,904 | -41.7% | 0.28% | -18.9% |
| Q3 2020 | $6,873,000 | +7.4% | 87,365 | -1.7% | 0.35% | +2.3% |
| Q2 2020 | $6,400,000 | – | 88,903 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 27,500 | $2,437,600 | 2.23% |
| Ranger Investment Management | 316,318 | $28,038,428 | 2.08% |
| Lighthouse Investment Partners, LLC | 142,100 | $12,595,744 | 1.39% |
| Lighthouse Investment Partners, LLC | 139,200 | $12,338,688 | 1.36% |
| EARNEST PARTNERS LLC | 2,402,352 | $212,944,481 | 1.30% |
| Lighthouse Investment Partners, LLC | 108,200 | $9,590,848 | 1.06% |
| MOODY ALDRICH PARTNERS LLC | 51,885 | $4,599,086 | 0.93% |
| MOUNTAIN PACIFIC INVESTMENT ADVISERS INC/ID | 125,435 | $11,118,558 | 0.81% |
| Champlain Investment Partners, LLC | 1,275,910 | $113,096,662 | 0.72% |
| EPIQ PARTNERS, LLC | 10,463 | $927,440 | 0.62% |